Evidence map›Paper›PMID 37727065›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Associations of cortical SPP1 and ITGAX with cognition and common neuropathologies in older adults.

Katia de Paiva Lopes, Lei Yu, Xianli Shen, Yiguo Qiu, Shinya Tasaki, Artemis Iatrou, Michal Schnaider Beeri, Nicholas T Seyfried, Vilas Menon, Yanling Wang and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Context-dependent roles of osteopontin in aging-related neurological disorders.The Journal of international medical research · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Metabolic stress and age drive inflammation and cognitive decline in mice and humans.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Katia de Paiva LopesRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA.
Lei YuRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA.
Xianli ShenDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Yiguo QiuDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Shinya TasakiRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA.
Artemis IatrouRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA.
Michal Schnaider BeeriJoseph Sagol Neuroscience Center, Sheba Medical Center, Ramat Gan, Israel.
Nicholas T SeyfriedGoizueta Alzheimer's Disease Research Center, Department of Neurology and Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA.
Vilas MenonCenter for Translational and Computational Neuroimmunology, Department of Neurology & Taub Institute for Research on Alzheimer's disease and the Aging Brain, Columbia University Irving Medical Center, New York, New York, USA.
Yanling WangRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA.
Julie A SchneiderRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA.
Harvey CantorDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
David A BennettRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA.
Rush University Medical Center · USHarvard University · USAlzheimer’s Disease Neuroimaging Initiative · USColumbia University · USDana-Farber Cancer Institute · USRutgers Sexual and Reproductive Health and Rights · NL

Funding

SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1991 to 2020
$49.1M
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
Rush Alzheimer's Disease Research CenterP30AG072975 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI Lisa L Barnes, Julie A. Schneider · 2021 to 2026
$24.7M
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF ADR01AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1998 to 2024
$21.4M
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targetsU01AG061356 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BENNETT, DAVID ALAN, DE JAGER, PHILIP L · 2018 to 2022
$13.7M
Pathway discovery, validation and compound identification for Alzheimer's disease - SupplementU01AG046152 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BENNETT, DAVID ALAN, DE JAGER, PHILIP L · 2013 to 2017
$13.6M
THE T-CELL RESPONSE TO ANTIGENR01AI048125 · NIAID · DANA-FARBER CANCER INSTITUTE · PI CANTOR, HARVEY · 2000 to 2021
$5.1M
NIAID NIH HHS R01 AI048125NIA NIH HHS P30 AG010161NIA NIH HHS P30 AG072975NIA NIH HHS P30AG10161NIA NIH HHS P30AG72975NIA NIH HHS R01 AG015819NIA NIH HHS R01 AG017917NIA NIH HHS R01AG15819NIA NIH HHS R01AG17917NIA NIH HHS U01 AG046152NIA NIH HHS U01 AG061356NIA NIH HHS U01AG46152
6 · The paper itself

Abstract

introductionThe secreted phosphoprotein 1 (SPP1) gene expressed by CD11c

methodsWe leveraged protein measurements, single-nuclei, and RNASeq data from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP) of over 1200 samples for association analysis.

resultsExpression of SPP1 and its encoded protein osteopontin were associated with faster cognitive decline and greater odds of common neuropathologies. At single-cell resolution,  integrin subunit alpha X (ITGAX) was highly expressed in microglia, where specific subpopulations were associated with AD and cerebral amyloid angiopathy. DISCUSSION: The study provides evidence of SPP1 and ITGAX association with cognitive decline and common neuropathologies identifying a microglial subset associated with disease.

Indexed as

Alzheimer DiseaseCerebral Amyloid AngiopathyCognitive DysfunctionAnimalsCD11 AntigensCognitionMiceOsteopontinCD11 AntigensItgax protein, mouseOsteopontinSpp1 protein, mouseCD11ccognitionITGAXmicroglianeuropathologiesOPNosteopontinRNASeqsnRNASeqSPP1

Identifiers

PMID37727065
PMCPMC10841499
OpenAlexW4386878019

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.